<!doctype html>
<html>
<head>
<meta charset="UTF-8">
<meta name="apple-mobile-web-app-capable" content="yes">
<meta name="viewport" content="width=device-height">
<meta name="apple-mobile-web-app-title" content="CSL Vaccines - Dukoral">
<title>CSL Vaccines - Dukoral</title>
<link rel="stylesheet" type="text/css" href="../css/style.css" />
<style type="text/css">
	.slide { background-image:url('../img/cover-bg.jpg'); }
	.slide .blk { right: auto; left: 50px; }
	.protection { overflow: hidden; }
	.protection li { float: left; width: 288px; font-size: 24px; line-height: 1em; text-align: center;}
	.protection li:nth-child(2) { margin: 0 28px; }
	.protection li > span { display: block; border-radius: 10px; padding: 22px; }
	.protection li > span:first-child { height: 120px; margin-bottom: 5px; background: #4c4c4c url('../img/sub-headers.svg') center 32px no-repeat; background-size: 215px auto; }
	.protection li:nth-child(2) > span:first-child { background-position: center -150px; }
	.protection li:last-child > span:first-child { background-position: center -331px; }
	.protection li > span:last-child { background-color: rgba(255,255,255, 0.7); min-height: 192px; }

</style> 
</head>
<body>
	<section class="slide">
        <article class="content">
           <h1 class="title">
          		<span>HELP PROTECT AT-RISK TRAVELLERS WITH <br />CHOLERA VACCINATION: DUKORAL<sup>3</sup></span>
           </h1>
            <ul class="protection">
            	<li>
            		<span></span>
            		<span>
            			*Satisfactory<br />
						protection 2 weeks<br />
						after last dose<sup>3</sup>
           			</span>
            	</li>
            	<li>
            		<span></span>
            		<span>
            			85% protective<br />
						efficacy against<br />
						cholera demonstrated<br />
						at 6 months after<br />
						primary course<sup>3</sup>
           			</span>
            	</li>
            	<li>
            		<span></span>
            		<span>
            			In clinical trials,<br />
						DUKORAL was<br />
						well tolerated, with<br />
						gastrointestinal<br />
						symptoms reported<br />
						at similar frequencies<br />
						in vaccine and<br />
						placebo groups<sup>3</sup>
					</span>
            	</li>
            </ul>
        </article>
        
        <!-- footer menu -->
        <footer>
        	<span class="btn arrow"><i></i></span>
            <ul class="nav">
                <li data-href="Dukoral_Map/DukoralMap" >Map</li>
                <li data-href="Dukoral_Cholera/Dukoral_cholera" class="">Cholera</li>
                <li data-href="Dukoral_at_Risk_Travellers/Dukoral_at_risk_travellers" >At-risk travellers</li>
                <li data-href="Dukoral_Offer_Before_They_Go/Dukoral_offer_before_they_go">DUKORAL</li>
                <li data-href="Dukoral_Summary/DukoralSummary">Summary</li>
                <li data-href="Dukoral_Vaccination/Dukoral_vaccination" >Vaccination schedule</li>
                <li data-href="Dukoral_Resources/Dukoral_Resources">Resources</li>
                
                 <li data-href="pi" ><span><i>PI</i></span></li>
                <li data-href="ref"><span><i></i></span></li>
            </ul>
            <div class="item refs hide">
            	<h3>REFERENCES</h3>
                <ol>
                    <li>Jelinek T <em>et al. Expert Rev. Vaccines</em> 2008; (7)5:561–567</li>
                    <li class="handbook">NHMRC, The Australian Immunisation Handbook, 10th Edition, 2013.</li>
                    <li>DUKORAL<sup>®</sup> Approved Product Information, August 2015.</li>
                    <li>Australian Bureau of Statistics, ABS Data, Short-Term Travellers. Last accessed June 2016.</li>
                    <li>Centres for Disease Control and Prevention. 2016 Yellow Book.<br />
Ch.3 Infectious Diseases Related to Travel.</li>
                    <li>Steffan R <em>et al. Trav Med Infect Dis</em> 2003; 1:80–88.</li>
                    <li>Zuckerman <em>et al. Lancet Infect Dis</em> 2007; 7:521–530.</li>
                    <li>Kozicki M <em>et al. Int J Epidemiol</em> 1985; 14(1):169–172.</li>
                    <li>Mattila L <em>et al. J Travel Med</em> 1995: 1;2(2):77–84.</li>
                </ol>
            </div>
            <div class="item pi hide">
            <p class="product"></p>
            	<p class="review">Before prescribing, please review Product Information available at <span class="pi_link">www.seqirus.com.au/PI</span>
</p>
				<p class="small">Seqirus (Australia) Pty Ltd. ABN 66 120 398 067, 63 Poplar Road Parkville, Victoria 3052. www.seqirus.com.au.<br /> 
Medical Information: 1800 642 865. ® DUKORAL is a registered trademark of Valneva Sweden AB.<br />  
Seqirus™ is a trademark of Seqirus UK Limited or its affiliates. Date of preparation: July 2016. DUKO/0716/0038. 13574. </p>
<p class="box"><strong>PBS Information:</strong> This product is not listed on the National Immunisation Program (NIP) Schedule or the PBS.</p>
            </div>
        </footer><!-- end footer -->
       
        <span class="btn border blk">
        	PRIMARY VACCINATION<br />SCHEDULE
        </span>
        <span class="logo"><i></i></span>
	</section>
<script type="text/javascript" src="../js/jquery-1.11.0.min.js"></script>
<script type="text/javascript" src="../js/touchy.js"></script>
<script type="text/javascript" src="../js/script.js"></script>

<script type="text/javascript">
	$( function(){
		$('.prev').on('tap', function(){
			goToSlide('../Dukoral_Map/DukoralMap');
		})
		
		///navigate
		navigate('../Dukoral_Map/DukoralMap', '../Dukoral_at_Risk_Travellers/Dukoral_at_risk_travellers');
	
	})
</script>
</body>
</html>
